Diabetes Care 26:2923-2928, 2003
© 2003 by the American Diabetes Association, Inc.
Pathophysiology/Complications Original Article |
Progression of Coronary Artery Calcification in Type 1 Diabetes
The importance of glycemic control
Janet K. Snell-Bergeon, MPH1,
John E. Hokanson, PHD, MPH1,
Lisa Jensen, RN2,
Todd MacKenzie, PHD3,
Gregory Kinney, MPH1,
Dana Dabelea, MD, PHD1,
Robert H. Eckel, MD2,
James Ehrlich, MD4,
Satish Garg, MD5 and
Marian Rewers, MD, PHD, MPH1,5
1 Department of Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, Colorado
2 Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado
3 Dartmouth University, Hanover, New Hampshire
4 Colorado Heart Imaging Center, Denver, Colorado
5 Barbara Davis Center for Childhood Diabetes, Denver, Colorado
Address correspondence and reprint requests to Janet K. Snell-Bergeon, MPH, Department of Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, 4200 East 9th Ave., Campus Box C245, Denver, CO 80262. E-mail: janet.snell-bergeon{at}uchsc.edu
OBJECTIVECoronary artery disease (CAD) occurs earlier in life and is more often fatal in people with type 1 diabetes. This excess risk seems to be higher than in those with type 2 diabetes and is poorly explained by conventional risk factors. The role of glycemic control is controversial and has not been previously addressed in a prospective manner using a reliable marker for subclinical CAD, such as coronary artery calcification (CAC), measured by electron beam computed tomography (EBCT).
RESEARCH DESIGN AND METHODSWe measured CAC twice during an interval of 2.7 years in 109 men and women with type 1 diabetes (aged 2250 years). Progression of CAC was found in 21 patients, based on change in the square root-transformed volume score.
RESULTSIn multiple logistic regression, CAC progression was associated with baseline hyperglycemia (odds ratio [OR] 7.11, 95% CI 1.3836.6, P = 0.02), adjusted for the presence of CAC at baseline (P = 0.01), duration of diabetes (P = 0.02), sex (P = 0.09), and age (P = 0.27). There was also a significant interactive effect of higher insulin dose and higher BMI (P = 0.03).
CONCLUSIONSIn conclusion, in this young cohort with type 1 diabetes, suboptimal glycemic control (HbA1c >7.5%) was a strong risk factor for progression of CAC. Insulin resistance may also play a role.
Abbreviations: CAC, coronary artery calcification CAD, coronary artery disease EBCT, electron beam- computed tomography EDC, Epidemiology of Diabetes Complications Study SRV, square root-transformed volume

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. M. Maahs, L. G. Ogden, A. Kretowski, J. K. Snell-Bergeon, G. L. Kinney, T. Berl, and M. Rewers
Serum Cystatin C Predicts Progression of Subclinical Coronary Atherosclerosis in Individuals With Type 1 Diabetes
Diabetes,
November 1, 2007;
56(11):
2774 - 2779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Savransky, A. Nanayakkara, J. Li, S. Bevans, P. L. Smith, A. Rodriguez, and V. Y. Polotsky
Chronic Intermittent Hypoxia Induces Atherosclerosis
Am. J. Respir. Crit. Care Med.,
June 15, 2007;
175(12):
1290 - 1297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Mazzone, P. M. Meyer, G. T. Kondos, M. H. Davidson, S. B. Feinstein, R. B. D'Agostino Sr., A. Perez, and S. M. Haffner
Relationship of Traditional and Nontraditional Cardiovascular Risk Factors to Coronary Artery Calcium in Type 2 Diabetes
Diabetes,
March 1, 2007;
56(3):
849 - 855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Cleary, T. J. Orchard, S. Genuth, N. D. Wong, R. Detrano, J.-Y. C. Backlund, B. Zinman, A. Jacobson, W. Sun, J. M. Lachin, et al.
The Effect of Intensive Glycemic Treatment on Coronary Artery Calcification in Type 1 Diabetic Participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
Diabetes,
December 1, 2006;
55(12):
3556 - 3565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Edelman, S. Garg, J. Frias, D. Maggs, Y. Wang, B. Zhang, S. Strobel, K. Lutz, and O. Kolterman
A Double-Blind, Placebo-Controlled Trial Assessing Pramlintide Treatment in the Setting of Intensive Insulin Therapy in Type 1 Diabetes
Diabetes Care,
October 1, 2006;
29(10):
2189 - 2195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. J. Goldberg and H. M. Dansky
Diabetic Vascular Disease: An Experimental Objective
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2006;
26(8):
1693 - 1701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kobayashi, Y. Hayashi, K. Taguchi, T. Matsumoto, and K. Kamata
ANG II enhances contractile responses via PI3-kinase p110{delta} pathway in aortas from diabetic rats with systemic hyperinsulinemia
Am J Physiol Heart Circ Physiol,
August 1, 2006;
291(2):
H846 - H853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. O. Schwab, J. Doerfer, W. Hecker, J. Grulich-Henn, D. Wiemann, O. Kordonouri, P. Beyer, R. W. Holl, and on behalf of the DPV Initiative of the German Work
Spectrum and Prevalence of Atherogenic Risk Factors in 27,358 Children, Adolescents, and Young Adults With Type 1 Diabetes: Cross-sectional data from the German diabetes documentation and quality management system (DPV)
Diabetes Care,
February 1, 2006;
29(2):
218 - 225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Raggi, A. Bellasi, and C. Ratti
Ischemia Imaging and Plaque Imaging in Diabetes: Complementary tools to improve cardiovascular risk management
Diabetes Care,
November 1, 2005;
28(11):
2787 - 2794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. McCullough
Effect of Lipid Modification on Progression of Coronary Calcification
J. Am. Soc. Nephrol.,
November 1, 2005;
16(11_suppl_2):
S115 - S119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. T. Bloomgarden
Inflammation, Atherosclerosis, and Aspects of Insulin Action
Diabetes Care,
September 1, 2005;
28(9):
2312 - 2319.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Libby, D. M. Nathan, K. Abraham, J. D. Brunzell, J. E. Fradkin, S. M. Haffner, W. Hsueh, M. Rewers, B. T. Roberts, P. J. Savage, et al.
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus
Circulation,
June 28, 2005;
111(25):
3489 - 3493.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Wadwa, G. L. Kinney, D. M. Maahs, J. Snell-Bergeon, J. E. Hokanson, S. K. Garg, R. H. Eckel, and M. Rewers
Awareness and Treatment of Dyslipidemia in Young Adults With Type 1 Diabetes
Diabetes Care,
May 1, 2005;
28(5):
1051 - 1056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Cassidy, L. F. Bielak, Y. Zhou, P. F. Sheedy II, S. T. Turner, J. F. Breen, P. A. Araoz, I. J. Kullo, X. Lin, and P. A. Peyser
Progression of Subclinical Coronary Atherosclerosis: Does Obesity Make a Difference?
Circulation,
April 19, 2005;
111(15):
1877 - 1882.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Maahs, G. L. Kinney, P. Wadwa, J. K. Snell-Bergeon, D. Dabelea, J. Hokanson, J. Ehrlich, S. Garg, R. H. Eckel, and M. J. Rewers
Hypertension Prevalence, Awareness, Treatment, and Control in an Adult Type 1 Diabetes Population and a Comparable General Population
Diabetes Care,
February 1, 2005;
28(2):
301 - 306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Abedin, Y. Tintut, and L. L. Demer
Vascular Calcification: Mechanisms and Clinical Ramifications
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2004;
24(7):
1161 - 1170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Hokanson, T. MacKenzie, G. Kinney, J. K. Snell-Bergeon, D. Dabelea, J. Ehrlich, R. H. Eckel, and M. Rewers
Evaluating Changes in Coronary Artery Calcium: An Analytic Method That Accounts for Interscan Variability
Am. J. Roentgenol.,
May 1, 2004;
182(5):
1327 - 1332.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|